The natural history and control of cytomegalovirus infection following allogeneic stem cell transplantation

被引：0
|
作者：
Gamett, G. [1 ]
Boeckh, M. [2 ]
Einsele, H. [3 ]
Emery, V. [4 ]
机构：
[1] Univ London Imperial Coll Sci Technol & Med, London, England
[2] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
[3] Univ Wurzburg, Wurzburg, Germany
[4] Royal Free & Univ Coll Med Sch, London WC1E 6BT, England
来源：
BONE MARROW TRANSPLANTATION | 2009年 / 43卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S237 / S238
页数：2
相关论文
共 50 条
  • [21] Cytomegalovirus DNAemia and disease: incidence, natural history and management in settings other than allogeneic stem cell transplantation
    Ng, Ashley P.
    Worth, Leon
    Chen, Luke
    Seymour, John F.
    Prince, H. Miles
    Slavin, Monica
    Thursky, Karin
    HAEMATOLOGICA, 2005, 90 (12) : 1672 - 1679
  • [22] The Economic and Health Utilization Cost of Clinically Significant Cytomegalovirus Infection Following Allogeneic Hematopoietic Stem Cell Transplantation
    Yong, Michelle K.
    Tio, Shio Yen
    Valentine, Jake
    Sasadeusz, Joe
    Chee, Lynette C. Y.
    Bajel, Ashish
    Ritchie, David
    Slavin, Monica
    BLOOD, 2019, 134
  • [23] Leflunomide failure to control recurrent cytomegalovirus infection in the setting of renal failure after allogeneic stem cell transplantation
    Battiwalla, M.
    Paplham, P.
    Almyroudis, N. G.
    McCarthy, A.
    Abdelhalim, A.
    Elefante, A.
    Smith, P.
    Becker, J.
    McCarthy, P. L.
    Segal, B. H.
    TRANSPLANT INFECTIOUS DISEASE, 2007, 9 (01) : 28 - 32
  • [24] The Impact of Letermovir Prescribing on the Rate of Cytomegalovirus Reactivation Following Allogeneic Stem Cell Transplantation
    Smith, Siobhan
    Duncan, Nick
    Ricketts, Laura
    O'Neill, Jessica
    Gautama, Brijesh
    Ibrahim, Abeer
    Jones, Ceri H.
    Kempshall, Emma
    Ingram, Wendy
    Wilson, Keith
    BONE MARROW TRANSPLANTATION, 2021, 56 (SUPPL 1) : 372 - 373
  • [25] Role of letermovir for prevention of cytomegalovirus infection after allogeneic haematopoietic stem cell transplantation
    Razonable, Raymund R.
    CURRENT OPINION IN INFECTIOUS DISEASES, 2018, 31 (04) : 286 - 291
  • [26] Immunosuppressive effect of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation.
    Giebel, S
    Maccario, R
    Avanzini, MA
    Marconi, M
    Rossi, G
    Gentile, R
    Travaglino, P
    Locatelli, F
    BLOOD, 2003, 102 (11) : 973A - 973A
  • [27] The immunosuppressive effect of human cytomegalovirus infection in recipients of allogeneic hematopoietic stem cell transplantation
    Giebel, S
    Maccario, R
    Lilleri, D
    Zecca, M
    Avanzini, MA
    Marconi, M
    Merlone, AD
    Campanini, G
    Montagna, D
    Travaglino, P
    Gentile, R
    Telli, S
    Pagliara, D
    Holowiecki, J
    Locatelli, F
    BONE MARROW TRANSPLANTATION, 2005, 36 (06) : 503 - 509
  • [28] Cytomegalovirus infection in children after allogeneic haematopoietic stem cell transplantation in a developing country
    Hazar, V.
    Uygun, V.
    Karasu, G.
    Eker, N.
    Tayfun, F.
    Kupesiz, A.
    Yesilipek, A.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S332 - S332
  • [29] Oral valganciclovir as preemptive therapy for cytomegalovirus infection post allogeneic stem cell transplantation
    Busca, A.
    de Fabritiis, P.
    Ghisetti, V.
    Allice, T.
    Mirabile, M.
    Gentile, G.
    Locatelli, F.
    Falda, M.
    TRANSPLANT INFECTIOUS DISEASE, 2007, 9 (02) : 102 - 107
  • [30] The immunosuppressive effect of human cytomegalovirus infection in recipients of allogeneic hematopoietic stem cell transplantation
    S Giebel
    R Maccario
    D Lilleri
    M Zecca
    M A Avanzini
    M Marconi
    A Di Cesare Merlone
    G Campanini
    D Montagna
    P Travaglino
    R Gentile
    S Telli
    D Pagliara
    J Holowiecki
    F Locatelli
    Bone Marrow Transplantation, 2005, 36 : 503 - 509
12345